Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Hunter

Showing results (171-180 of 212) with videos related to

Pageof 22
Sort By:
Plos Pathogens|April 19, 2021
Plasmacytoid dendritic cells have divergent effects on HIV infection of initial target cells and induce a pro-retention phenotypeOrion Tong, Gabriel Duette, Thomas R O'Neil, et al.
Journal of Clinical Microbiology|November 13, 2009
HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infectionSurender Khurana, Philip J Norris, Michael P Busch, et al.
Annals of the American Thoracic Society|June 11, 2026
Elexacaftor-Tezacaftor-Ivacaftor for Individuals with Residual CFTR Activity: An Open-Label, Nonrandomized Clinical TrialRachel W Linnemann, George M Solomon, Adrianna L Westbrook, et al.
Virus Evolution|January 21, 2026
Single genome amplification and molecular cloning of HIV-1 populations in acute HIV-1 infection: implications for studies on HIV-1 diversity and evolutionary rateAnthony Y Y Hsieh, Amin S Hassan, Jamirah Nazziwa, et al.
Plos Pathogens|February 8, 2021
The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infectionTysheena P Charles, Samantha L Burton, Prabhu S Arunachalam, et al.
The Journal of Experimental Medicine|August 24, 2016
Balance between transmitted HLA preadapted and nonassociated polymorphisms is a major determinant of HIV-1 disease progressionDaniela C Mónaco, Dario A Dilernia, Andrew Fiore-Gartland, et al.
The Journal of Experimental Medicine|May 4, 2005
Antigenic conservation and immunogenicity of the HIV coreceptor binding siteJulie M Decker, Frederic Bibollet-Ruche, Xiping Wei, et al.
Frontiers in Virology (Lausanne, Switzerland)|August 19, 2022
Attenuated HIV-1 Nef But Not Vpu Function in a Cohort of Rwandan Long-Term SurvivorsGisele Umviligihozo, Jaclyn K Mann, Steven W Jin, et al.
Journal of Virology|May 18, 2007
Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infectionHayley Crawford, Julia G Prado, Alasdair Leslie, et al.
Journal of Virology|May 29, 2015
Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 EnvelopeKatie M Kilgore, Megan K Murphy, Samantha L Burton, et al.
Pageof 22

Showing results (171-180 of 212) with videos related to

Sort By:
Pageof 22
Plos Pathogens|April 19, 2021
Plasmacytoid dendritic cells have divergent effects on HIV infection of initial target cells and induce a pro-retention phenotypeOrion Tong, Gabriel Duette, Thomas R O'Neil, et al.
Journal of Clinical Microbiology|November 13, 2009
HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infectionSurender Khurana, Philip J Norris, Michael P Busch, et al.
Annals of the American Thoracic Society|June 11, 2026
Elexacaftor-Tezacaftor-Ivacaftor for Individuals with Residual CFTR Activity: An Open-Label, Nonrandomized Clinical TrialRachel W Linnemann, George M Solomon, Adrianna L Westbrook, et al.
Virus Evolution|January 21, 2026
Single genome amplification and molecular cloning of HIV-1 populations in acute HIV-1 infection: implications for studies on HIV-1 diversity and evolutionary rateAnthony Y Y Hsieh, Amin S Hassan, Jamirah Nazziwa, et al.
Plos Pathogens|February 8, 2021
The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infectionTysheena P Charles, Samantha L Burton, Prabhu S Arunachalam, et al.
The Journal of Experimental Medicine|August 24, 2016
Balance between transmitted HLA preadapted and nonassociated polymorphisms is a major determinant of HIV-1 disease progressionDaniela C Mónaco, Dario A Dilernia, Andrew Fiore-Gartland, et al.
The Journal of Experimental Medicine|May 4, 2005
Antigenic conservation and immunogenicity of the HIV coreceptor binding siteJulie M Decker, Frederic Bibollet-Ruche, Xiping Wei, et al.
Frontiers in Virology (Lausanne, Switzerland)|August 19, 2022
Attenuated HIV-1 Nef But Not Vpu Function in a Cohort of Rwandan Long-Term SurvivorsGisele Umviligihozo, Jaclyn K Mann, Steven W Jin, et al.
Journal of Virology|May 18, 2007
Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infectionHayley Crawford, Julia G Prado, Alasdair Leslie, et al.
Journal of Virology|May 29, 2015
Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 EnvelopeKatie M Kilgore, Megan K Murphy, Samantha L Burton, et al.
Pageof 22